Concepedia

Hugo Calderón

HC

Statistics

Publications

6

Citations

193

H-Index

6

Active since

2016

Affiliations

PsiOxus Therapeutics (United Kingdom)(Current)

University of Oxford

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Universitat de Barcelona

Institut Català d'Oncologia

Hugo Calderón is an author at PsiOxus Therapeutics (United Kingdom) specializing in life sciences, oncology, and immunology.

ORCID

Publications per year

2016–2024

6

Publications

6

CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition

Irene Andreu-Saumell, Alba Rodríguez-García, Vanessa Mühlgrabner et al. · Nature Communications · 2024 · 60 citations · Full text

, , +17

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators

Arthur Dyer, Ying Di, Hugo Calderón et al. · Molecular Therapy — Oncolytics · 2016 · 54 citations · Full text

, , +16

Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes

Nalini Marino, Sam Illingworth, Prithvi Kodialbail et al. · PLoS ONE · 2017 · 31 citations · Full text

, , +17

Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections

Natalia Egri, Hugo Calderón, Robert Martinez et al. · Frontiers in Immunology · 2023 · 18 citations · Full text

, , +17

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

, , +17

1–5 of 6